Who are the young biopharma leaders shaping the industry? Nominate them for Endpoints' special report
We were in the homestretch for our annual 20 under 40 project when the pandemic hit the US. On March 8, I canceled my train tickets to Boston to meet with nominees Jason Kelly at Ginkgo and David Cheng. The next day was the first warm day in New York City, and the streets and parks were littered with joggers and families out chatting in shrill, voluble tones after three months cooped in the cold. I spoke amiably on the phone with Otello Stampacchia about how biotech was adapting and about his family in Italy, the crisis there and the crisis coming. The WHO declared a pandemic two days later. Soon, no one was out.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.